About Chaim Sheba Medical Center; Hematology BMT & CBB
Chaim Sheba Medical Center at Tel HaShomer, also Tel HaShomer Hospital, is the largest hospital in Israel, located in the Tel Aviv District city of Ramat Gan at Tel HaShomer neighborhood, Israel. In 2020, Newsweek ranked it as the 9th-best hospital in the world.
There are 1,580 beds in Chaim Sheba Medical Center; Hematology BMT & CBB.
Clinical Trials at Chaim Sheba Medical Center; Hematology BMT & CBB
During the past decade, Chaim Sheba Medical Center; Hematology BMT & CBB conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 5 clinical trials were completed, i.e. on
average, 250% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Chaim Sheba Medical Center; Hematology BMT & CBB"
#1 collaborator was "German Low Grade Lymphoma Study Group" with 1 trials as a collaborator and "Institute of Cancer Research, United Kingdom" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were
collaborators in the rest 2 trials.
Clinical Trials Conditions at Chaim Sheba Medical Center; Hematology BMT & CBB
According to Clinical.Site data, the most researched conditions in "Chaim Sheba Medical Center; Hematology BMT & CBB" are
"Non-Hodgkin's Lymphoma" (2 trials), "Blood Cancer" (1 trials), "Diffuse Large B Cell Lymphoma" (1 trials), "Hematological Malignancy" (1 trials) and "Influenza, Human" (1 trials). Many other conditions were trialed in "Chaim Sheba Medical Center; Hematology BMT & CBB" in a lesser frequency.
Clinical Trials Intervention Types at Chaim Sheba Medical Center; Hematology BMT & CBB
Most popular intervention types in "Chaim Sheba Medical Center; Hematology BMT & CBB" are "Drug" (6 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "Obinutuzumab" (2 trials), "rituximab [MabThera/Rituxan]" (2 trials), "89Zr-Df-IAB22M2C" (1 trials), "Atezolizumab" (1 trials) and "Bendamustine" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Chaim Sheba Medical Center; Hematology BMT & CBB
The vast majority of trials in "Chaim Sheba Medical Center; Hematology BMT & CBB" are
6 trials for "All" genders.
Clinical Trials Status at Chaim Sheba Medical Center; Hematology BMT & CBB
Currently, there are NaN active trials in "Chaim Sheba Medical Center; Hematology BMT & CBB".
undefined are not yet recruiting,
1 are recruiting,
undefined are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 4 completed trials in Chaim Sheba Medical Center; Hematology BMT & CBB,
undefined suspended trials,
and 1 terminated clinical trials to date.
Out of the total trials that were conducted in Chaim Sheba Medical Center; Hematology BMT & CBB, 2 "Phase 1"
clinical trials were conducted, 2 "Phase 2" clinical
trials and 3 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 1 trials, and there were
also 0 trials that are defined as “Not Applicable".